TDC
BIOA

Thompson Davis & Co’s BioAmber Inc. BIOA Stock Holding History

Thompson Davis & Co’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-100
Closed -$1K – 1316
2014
Q4 		$1K Buy
+100
New +$910 ﹤0.01% 1152
2014
Q3 		– Sell
-250
Closed -$2K – 1309
2014
Q2 		$2K Sell
250
-500
-67% -$5.16K ﹤0.01% 730
2014
Q1 		$9K Buy
+750
New +$8.88K 0.01% 523

Other funds holding BIOA

WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PRCM
Pine River Capital Management Minnetonka, Minnesota $32.9M AUM 4.47% 1-Year Est. Return
ACPU
Arrowgrass Capital Partners (US) Dover, Delaware $380M AUM 20.87% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Thompson Davis & Co's BIOA Position: Q1 2015 in Review

Thompson Davis & Co sold out of BioAmber Inc. (BIOA) in Q1 2015, closing a stake of 100 shares — an estimated $1K sold.

Thompson Davis & Co first reported a position in BIOA in Q1 2014 and held it in 3 quarters. The position peaked at $9K in Q1 2014. 35 funds tracked by Wall St. Rank hold BIOA as of Q1 2015.

  • Thompson Davis & Co reported no remaining BioAmber Inc. position as of Q1 2015 after selling out during the quarter.
  • Thompson Davis & Co sold 100 BioAmber Inc. shares in Q1 2015, an estimated $1K.
  • Thompson Davis & Co first reported a position in BioAmber Inc. in Q1 2014 and held it in 3 quarters.
  • Thompson Davis & Co's BioAmber Inc. position peaked at $9K in Q1 2014.
  • 35 funds tracked by Wall St. Rank held BioAmber Inc. as of Q1 2015.

Based on Thompson Davis & Co's 13F filing for Q1 2015, filed 28 Apr 2015.